A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences

BACKGROUND: Anti-IgE (omalizumab) and anti-IL5/IL5R (reslizumab, mepolizumab and benralizumab) treatments are available for severe allergic and eosinophilic asthma. In these patients, studies have shown beneficial effects in oral corticosteroid use and exacerbations. The aim of this retrospective si...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotisalmi, Emma, Hakulinen, Auli, Mäkelä, Mika, Toppila-Salmi, Sanna, Kauppi, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222440/
https://www.ncbi.nlm.nih.gov/pubmed/32467765
http://dx.doi.org/10.1186/s40733-020-00055-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222440/
https://www.ncbi.nlm.nih.gov/pubmed/32467765
http://dx.doi.org/10.1186/s40733-020-00055-9

Ejemplares similares